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Unfortunately, despite the intensive therapy, there is continuing viral replication at levels below 24 the limits of detection of most clinical assays due to inefficient antiviral pharmacodynamics that 25 create environments where drug potency is reduced (12, 13, 41, 43). For example, there is recent 26 evidence for ongoing HIV replication in gut-associated lymphoid tissue during long-term 27 antiretroviral therapy (7). A second cause of HIV treatment failure is the creation of a 28 subpopulation of HIV-infected CD4 + T-lymphocytes that harbors latent replication-competent 29 proviruses. Since no viral proteins are produced, the latently infected cells cannot be recognized 30 by the antiviral immune response and are highly resistant to antiretroviral therapy. The 31 development of these latent and slowly replicating viral reservoirs during HIV infections has 32 immense practical consequences for treatment of HIV infections because it provides a 33 mechanism that allows the virus to evade immune clearance and the effects of antiviral drugs 34 while still retaining an ability to quickly revert to the productive state upon interruption of drug 35 therapy or in response to cellular activation signals (6, 17) . 36
Multiple complementary mechanisms are required to silence HIV transcription and 37 permit its entry into latency. Although HIV silencing can readily occur in transformed cell lines, 38 several features of the metabolism of resting CD4 cells ensure that latent proviruses remain 39 transcriptionally inactive for long periods. First, a key factor contributing to the restricted 40 transcriptional initiation that is characteristic of HIV transcriptional silencing is the sequestration 41 of the cellular initiation factors NF-κB and NFAT in the cytoplasm of quiescent T-cells (28, 37). 42
The second major transcriptional block seen in latently infected cells is the incorporation of the 43
Whereas there is compelling evidence that silencing through histone remodeling is a key 66 feature mediating the establishment of HIV latency, the involvement of DNA methylation is 67 more controversial. Recent studies have shown that proviruses that are poorly responsive to T-68 cell activation signals also tend to be hypermethylated (26). However, in many silenced HIV 69 clones proviral expression does not correlate with DNA methylation (42). Thus it seems likely 70 that although DNA methylation is a powerful silencing mechanism for retroviruses, in the natural 71 setting, DNA methylation is not inevitably imposed and partially methylated promoters can still 72 be reactivated (26) . ex vivo method that permits, for the first time, the generation of large populations of latently 98 infected primary CD4 + T-cells. We have used this system to demonstrate that both creation of 99 heterochromatic structures on the HIV provirus and restrictions in P-TEFb levels contribute to 100 the establishment of HIV latency in primary cells. 101
Results

143
Efficient generation of pure populations of latently infected CD4 + memory T-cells. 144
We have developed a novel ex vivo model system to study HIV latency in primary CD4 + T-cells. 145
As outlined in Fig. 1 , pure populations (~97 %) of primary CD4 + T-cells were isolated from 146 peripheral blood mononuclear cells (PBMCs) using a negative selection MACS kit from 147
Miltenyi Biotech. The cells were then expanded using α-CD3/CD28 antibody coated beads in 148 the presence of IL-2. After four days the cells were infected with HIV-derived vectors ( Fig. 2A ) 149 that express fluorescent protein reporter genes (either the short-lived d2EGFP or mCherry) in 150 place of the Nef gene, as previously described (27, 49). Like HIV itself, the viruses included the 151 regulatory proteins Tat and Rev, which provide a positive feedback circuit that enhances HIV 152 transcriptional elongation and export of mRNA from the nucleus. In the majority of our 153 experiments, in order to increase the frequency of latently infected cells in the population, we 154 utilized Tat carrying the H13L mutation. This partially attenuated Tat variant was originally 155 identified in the U1 latently infected cell line (16, 44), and was earlier shown by us to expedite 156 HIV entry into latency (40). The use of an attenuated Tat mutant is consistent with recent 157 studies which have shown that latently infected cells accumulate Tat variants with reduced trans-158 activation potential (55). However, as described below, latently infected cells can also be readily 159 generated using wildtype Tat. 160
To obtain a homogeneous population of HIV infected cells, cells expressing the 161 fluorescent reporters were purified by cell sorting. The purified cells were further expanded with 162 magnetic beads with α-CD3/CD28 antibodies. After 4 to 6 weeks, the cell population reached 163 between 50 to 100 x 10 6 cells, and the magnetic beads were removed and the cells were placed 164 on H80 feeder cells in presence of IL-2, as originally described by Cloyd and colleagues (45). efficiently reactivated by stimulation of the T-cell receptor (Fig. 8B) . Importantly, the quiescent 174 T-cells can be maintained on the H80 feeder cells for more than six months without any 175 noticeable loss of viability or reactivation capability. 176
The progressive silencing of HIV gene expression as cells enter quiescence can also be 177 observed using viruses carrying wildtype Tat (Fig. 3A) . In this experiment 86.15 % of the cells 178 carrying proviruses became silenced by Day 63. After stimulation of the T-cell receptor by 179 antibodies to CD3 and CD28, 90.99 % of the cells were reactivated. As previously observed in 180 our studies using Jurkat T-cells (40), the silencing of proviruses carrying the wildtype Tat is 181 generally slower and less efficient than silencing of proviruses carrying attenuated Tat genes. 182
The silencing of HIV proviruses was also observed in CD4 + T-cells derived from tonsil 183 tissues infected with viruses carrying either H13L Tat or wildtype Tat and the mCherry 184 fluorescent reporter (Fig. 3B) (Fig. 4) . CD38 is only expressed at very low levels on naïve T-cells and unactivated memory T-213 cells, but is present at high levels on both activated T-cells and mature thymocytes (11). 214
Consistent with these observations, we observed that freshly isolated naïve and memory cells 215 express only low levels of CD38 (Fig. 4C) . By contrast, the latently infected memory (CD45RA Finally, as d2EGFP levels increase (Fig. 5A) , there is a concomitant decrease in levels of 235 CD4 (Fig. 5F ). The downregulation of CD4 is probably due to the increased expression of HIV 236 proteins (Vpu and Env) from the latent proviruses. 237
Very similar patterns of surface marker expression were observed in cells obtained from 238 a second donor that were infected with viruses carrying the wildtype Tat gene (Fig. 6) . In this 239 cell population 96.38 % of the infected cells did not express the d2EGFP marker and the 240 remainder only expressed low levels of d2EGFP. However, 66.45 % of the cells became 241 strongly activated following stimulation of the TCR (Fig 6A) . As in the previous experiment, 242 the latently infected cells are all CD45RA -/CD45RO + (Fig. 6B) , and expressed low levels of 243 CD27 (Fig. 6D ) and CCR7 (Fig. 6E) , both of which became somewhat upregulated after TCR 244 activation. The cells also showed strong upregulation of CD25 (Fig. 6C ) and strong 245 downregulation of CD4 upon stimulation of the TCR (Fig. 6F) . regulation of both Ki67 and CD25 in over 96% of the cells (Fig. 7B ). Thus the latently infected 268 cells appear to be replicating slowly but they can be readily reactivated. As previously noted, 269 CCR7 expression is also upregulated when these cells were activated (Fig. 7C) . 270 NF-κ κ κ κB is necessary but not sufficient to activate latently infected primary CD4 + T 271
cells. Work by Zack and colleagues has shown that, in contrast to Jurkat cells, induction of NF-272 κB is necessary but not sufficient to induce latent proviruses in naïve primary T-cells (3). 273
Similarly, we have found that TNF-α is unable to induce latent proviruses in central memory T-274 cells ( Fig. 8B ) although it is a potent inducer of proviral expression in latently infected Jurkat T-275 cells (Fig. 8A ). By contrast, as described above, activation of the TCR strongly activates HIV 276 transcription in both Jurkat T-cells ( Fig. 8A ) and latently infected primary CD4 + T-cells. To 277 confirm that NF-κB was activated in the primary cells by both TNF-α and activation of the TCR, 278
we performed western blots to measure the nuclear levels of the NF-κB p65 subunit. As shown 279
in Fig. 8C , nuclear levels of p65 increase more than 10-fold following exposure of the quiescent 280 cells to either activator. 281
We next examined whether P-TEFb levels are limiting in these cells, as was originally 282
reported by Rice and his colleagues for freshly isolated PMBCs (22). As shown in Fig. 8C , 283 nuclear extracts of the latent cells show very low levels of CDK-9 and CycT1. There is no 284 increase in the nuclear levels of CDK-9 and CycT1 following exposure to TNF-α. By contrast, 285 activation of the TCR leads to a greater than 5-fold increase in CDK-9 and a greater than 50-fold 286 increase in CycT1. This strongly suggests that P-TEFb levels are limiting in the latently infected 287 memory cells and that both NF-κB and P-TEFb have to be activated in order to induce proviral 288 transcription at both initiation and elongation steps of transcription. 289
Latent proviruses in primary CD4
+ cells have heterochromatic structures. Extensive 290 studies in transformed cell systems have shown that latent HIV proviruses typically contain high 291 levels of histone deacetylases and heterochromatic structures (9, 14, 35, 49, 50). It is believed 292 that these chromatin modifications are used to restrict transcription initiation and thus promote 293 viral entry into latency (49). In primary cells, entry into latency is associated with differentiation 294 events leading to entry of cells into a quiescent state (31). Because it is not known whether 295 some, or all, of the chromatin silencing mechanisms seen in the transformed cells are also 296 observed in primary cells, we used chromatin immunoprecipitation (ChIP) assays to study the 297 chromatin of latent HIV proviruses in our primary CD4
+ T-cell model. 298
As shown in Fig. 9B , the latently infected CD4+ T cells have low, but detectable, levels 299 of RNAP II at the promoter region of the LTR (-116 to +4). Similarly to Jurkat T-cells, HDAC-1 300 is also present at high levels whereas the levels of acetylated histone H3 were very low. We have 301 previously reported that CBF-1 acts as an effective recruiter of HDACs to the HIV LTR (49). As 302 shown in Fig. 9B , CBF-1 and its co-factors CIR and mSin3A are all present on the latent 303 proviruses in primary cells. Induction of the latently infected cells by treating them with α-304 CD3/CD28 antibodies increased RNAP II levels at the promoter over 7-fold. By contrast, levels 305 of the repressors CBF-1, CIR, mSIN3A and HDAC-1 fell substantially. As expected, treatment 306 of latent primary CD4+ lymphocytes with α-CD3/CD28 antibodies resulted in NF-κB p65 and 307 histone acetyltransferase p300 recruitment to the promoter. Following TCR activation there was 308 a 4-fold to 7-fold increase in acetylated histone H3 present at the provirus. The latent proviruses 309 also carry heterochromatic markers at the promoter region of the LTR, including trimethylated 310 histone H3 at positions K9 and K27 (Fig. 9B ). HP1-α, a heterochromatic protein which binds 311 exclusively to trimethyl-K9-H3 histones is also present at the HIV LTR (14). Following TCR 312 activation, there were significant decreases in the levels of trimethylated histone H3 (K9 and 313 K27) and in the HP1-α repressor protein, while the levels of acetylated histones rises at the HIV 314
LTR. 315
Similar results were obtained using primers directed to the upstream nucleosome-0 region 316 of the LTR (Fig. 9A ) and the downstream nucleosome 1 (Fig. 9C ) and nucleosome 2 (Fig. 9D)  317 regions. Because the resolution of the ChIP assay is between 500 and 700 bp there is some 318 signal overlap between each of these adjacent regions. Nonetheless, some important differences 319 in protein distribution can be observed. The most notable difference is that there are much 320 higher levels of histones present in the nucleosome 0 and 1 regions than at the promoter of the 321 latent proviruses. These observations are consistent with previous studies using transformed cell 322 lines that demonstrated that the HIV promoter region is relatively devoid of histones (51). The 323 on August 15, 2017 by guest http://jvi.asm.org/ data also demonstrates that modified histones are present both upstream and downstream of the 324 transcription start site. By contrast, as expected, p65 is largely restricted to the promoter region 325 (Fig. 9D) . in primary cells appears to be due to limiting quantities of free P-TEFb, which we have measured 406
by examining the levels of CDK-9 and CycT1 present in nuclear extracts. Under the extraction 407 conditions we have used, the large, inactive form of P-TEFb is found in the cytoplasmic fraction 408
(1). Consistent with observations made in freshly isolated PMBCs (22), activation of the cells 409 through the TCR produces a dramatic upregulation of P-TEFb. In our experiments, this 410 activation of P-TEFb is demonstrated by the greater than 20-fold increase in the levels of CDK-9 411 and CycT1 in the nuclear extracts following activation of latently infected cells by antibodies to 412 CD3 and CD28. 413
In summary, the model system we have described presents exciting opportunities to study 414 specific molecular aspects of both the entry and exit from HIV latency. 
